drugset / Trial / NCT01092052
Study of NMS-1116354 in Advanced/Metastatic Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety profile of NMS-1116354, a CDC7 kinase inhibitor, in adult patients with advanced/metastatic solid tumors.
Timeline
- Start
- 2010-01
- Primary completion
- 2012-07
- Completion
- —
Outcome
Outcome not reported
Stopped: “Discontinuation of clinical investigation with NMS-1116354”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NMS-1116354 | Unknown | — | Oral |
Indications
No indication recorded.